Tandem Diabetes Care, Inc. (TNDM) Stock
Healthcare · Medical Devices · Member of Other US Stocks
Tandem Diabetes Care, Inc. (TNDM) closed at USD 16.01 on 2026-10-14, a change of +6 % over the past year, with a market capitalization of USD 1.15B.
Tandem Diabetes Care, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 16.01 |
| 2026-10-13 | 16.65 |
| 2026-10-12 | 16.45 |
| 2026-10-09 | 16.11 |
| 2026-10-08 | 15.68 |
| 2026-10-07 | 15.84 |
| 2026-10-06 | 16.16 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Tandem Diabetes Care, Inc. key figures
- Previous close
- USD 16.01 (2026-10-14)
- 1-year change
- +6 %
- Market cap
- USD 1.15B
- Enterprise value
- USD 1.43B
- P/E ratio (trailing)
- -18.36
- P/E ratio (forward)
- 103.93
- EPS (trailing)
- -0.90
- EPS (forward)
- 0.16
- PEG ratio
- n/a
- Price to book
- 8.81
- Revenue growth
- 5.8 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 6.36
- Employees
- 2,500
- Analyst consensus (third-party)
- buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Tandem Diabetes Care, Inc. and compare it with other stocks.
Analyze TNDMAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Tandem Diabetes Care, Inc. shares.